The Latest Breaking News from Palisade

Hyundai Sales Are Soaring Thanks To Hybrids

The Korean automaker saw its best ever half-year of sales with one-third coming from electrified vehicles.

Motor1 · Jul 2

Trump heads to China to spread the gospel of American tech

Tim Cook and Elon Musk, among other tech CEOS, will accompany the US president on a trip to Beijing

The Guardian - US · May 12

‘No one has done this in the wild’: study observes AI replicate itself

World is approaching point where no one can shut down a rogue AI, says director of body behind study

The Guardian - UK · May 7

OpenAI’s o3 Model Refused to Shut Down, Even When Told To

OpenAI's o3 Model is back in the headlines, but this time, due to the controversy surrounding it. According to the latest test run by an independent

Geekflare · May 26, 2025

Latest OpenAI models ‘sabotaged a shutdown mechanism’ despite commands to the contrary

Researchers observe the latest OpenAI models sabotaging shutdown attempts, despite explicit commands to allow such interruptions.

Tom’s Hardware · May 26, 2025

Edmunds: The best three-row SUVs of 2023

Three-row SUVs have been a popular choice among car shoppers with large families

The Independent UK · Jun 28, 2023

Next-Gen Hyundai Palisade Coming In 2025 With Hybrid Setup: Report

The naturally aspirated 3.8-liter engine could be dropped in favor of a turbo 3.5-liter.

Motor1 · Jun 2, 2023

Edmunds compares: Honda Pilot vs. Hyundai Palisade

The Honda Pilot and Hyundai Palisade are midsize SUVs with three rows of seating and a reputation for comfort and value

The Independent UK · May 10, 2023

2023 Hyundai Palisade Review: Luxe On A Budget

The Palisade Calligraphy packs premium features and high-end styling that puts it near the top of the class.

Motor1 · Mar 2, 2023

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. Bluebird shares traded in a range of $6.13 to $8.18 on a day…

Benzinga · Aug 17, 2022